- Title
- The Stroke Prognosis Instrument II (SPI-II)
- Creators
- Walter N Kernan - From the Departments of Internal Medicine (W.N.K., C.M.V., R.I.H.), Epidemiology and Public Health (L.M.B., R.W.M., R.I.H.), Neurology (L.M.B.), Psychiatry (P.M.S.), and Obstetrics and Gynecology (P.M.S.), Yale University School of Medicine, New Haven, Conn; Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University (R.S.S., M.G.) and Clinical Trials Methodology Group, Hamilton Civic Hospitals Research Centre (M.G.), Hamilton, Ontario, Canada; DepartmentCatherine M Viscoli - From the Departments of Internal Medicine (W.N.K., C.M.V., R.I.H.), Epidemiology and Public Health (L.M.B., R.W.M., R.I.H.), Neurology (L.M.B.), Psychiatry (P.M.S.), and Obstetrics and Gynecology (P.M.S.), Yale University School of Medicine, New Haven, Conn; Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University (R.S.S., M.G.) and Clinical Trials Methodology Group, Hamilton Civic Hospitals Research Centre (M.G.), Hamilton, Ontario, Canada; DepartmentLawrence M Brass - From the Departments of Internal Medicine (W.N.K., C.M.V., R.I.H.), Epidemiology and Public Health (L.M.B., R.W.M., R.I.H.), Neurology (L.M.B.), Psychiatry (P.M.S.), and Obstetrics and Gynecology (P.M.S.), Yale University School of Medicine, New Haven, Conn; Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University (R.S.S., M.G.) and Clinical Trials Methodology Group, Hamilton Civic Hospitals Research Centre (M.G.), Hamilton, Ontario, Canada; DepartmentRobert W Makuch - From the Departments of Internal Medicine (W.N.K., C.M.V., R.I.H.), Epidemiology and Public Health (L.M.B., R.W.M., R.I.H.), Neurology (L.M.B.), Psychiatry (P.M.S.), and Obstetrics and Gynecology (P.M.S.), Yale University School of Medicine, New Haven, Conn; Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University (R.S.S., M.G.) and Clinical Trials Methodology Group, Hamilton Civic Hospitals Research Centre (M.G.), Hamilton, Ontario, Canada; DepartmentPhilip M Sarrel - From the Departments of Internal Medicine (W.N.K., C.M.V., R.I.H.), Epidemiology and Public Health (L.M.B., R.W.M., R.I.H.), Neurology (L.M.B.), Psychiatry (P.M.S.), and Obstetrics and Gynecology (P.M.S.), Yale University School of Medicine, New Haven, Conn; Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University (R.S.S., M.G.) and Clinical Trials Methodology Group, Hamilton Civic Hospitals Research Centre (M.G.), Hamilton, Ontario, Canada; DepartmentRobin S Roberts - From the Departments of Internal Medicine (W.N.K., C.M.V., R.I.H.), Epidemiology and Public Health (L.M.B., R.W.M., R.I.H.), Neurology (L.M.B.), Psychiatry (P.M.S.), and Obstetrics and Gynecology (P.M.S.), Yale University School of Medicine, New Haven, Conn; Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University (R.S.S., M.G.) and Clinical Trials Methodology Group, Hamilton Civic Hospitals Research Centre (M.G.), Hamilton, Ontario, Canada; DepartmentMichael Gent - From the Departments of Internal Medicine (W.N.K., C.M.V., R.I.H.), Epidemiology and Public Health (L.M.B., R.W.M., R.I.H.), Neurology (L.M.B.), Psychiatry (P.M.S.), and Obstetrics and Gynecology (P.M.S.), Yale University School of Medicine, New Haven, Conn; Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University (R.S.S., M.G.) and Clinical Trials Methodology Group, Hamilton Civic Hospitals Research Centre (M.G.), Hamilton, Ontario, Canada; DepartmentPeter Rothwell - From the Departments of Internal Medicine (W.N.K., C.M.V., R.I.H.), Epidemiology and Public Health (L.M.B., R.W.M., R.I.H.), Neurology (L.M.B.), Psychiatry (P.M.S.), and Obstetrics and Gynecology (P.M.S.), Yale University School of Medicine, New Haven, Conn; Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University (R.S.S., M.G.) and Clinical Trials Methodology Group, Hamilton Civic Hospitals Research Centre (M.G.), Hamilton, Ontario, Canada; DepartmentRalph L Sacco - From the Departments of Internal Medicine (W.N.K., C.M.V., R.I.H.), Epidemiology and Public Health (L.M.B., R.W.M., R.I.H.), Neurology (L.M.B.), Psychiatry (P.M.S.), and Obstetrics and Gynecology (P.M.S.), Yale University School of Medicine, New Haven, Conn; Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University (R.S.S., M.G.) and Clinical Trials Methodology Group, Hamilton Civic Hospitals Research Centre (M.G.), Hamilton, Ontario, Canada; DepartmentRuei-Che Liu - From the Departments of Internal Medicine (W.N.K., C.M.V., R.I.H.), Epidemiology and Public Health (L.M.B., R.W.M., R.I.H.), Neurology (L.M.B.), Psychiatry (P.M.S.), and Obstetrics and Gynecology (P.M.S.), Yale University School of Medicine, New Haven, Conn; Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University (R.S.S., M.G.) and Clinical Trials Methodology Group, Hamilton Civic Hospitals Research Centre (M.G.), Hamilton, Ontario, Canada; DepartmentBernadette Boden-Albala - From the Departments of Internal Medicine (W.N.K., C.M.V., R.I.H.), Epidemiology and Public Health (L.M.B., R.W.M., R.I.H.), Neurology (L.M.B.), Psychiatry (P.M.S.), and Obstetrics and Gynecology (P.M.S.), Yale University School of Medicine, New Haven, Conn; Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University (R.S.S., M.G.) and Clinical Trials Methodology Group, Hamilton Civic Hospitals Research Centre (M.G.), Hamilton, Ontario, Canada; DepartmentRalph I Horwitz - From the Departments of Internal Medicine (W.N.K., C.M.V., R.I.H.), Epidemiology and Public Health (L.M.B., R.W.M., R.I.H.), Neurology (L.M.B.), Psychiatry (P.M.S.), and Obstetrics and Gynecology (P.M.S.), Yale University School of Medicine, New Haven, Conn; Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University (R.S.S., M.G.) and Clinical Trials Methodology Group, Hamilton Civic Hospitals Research Centre (M.G.), Hamilton, Ontario, Canada; Department
- Publication Details
- Stroke (1970), Vol.31(2), pp.456-462
- Academic Unit
- Leadership Department; Miller School of Medicine; UMMG Department of Neurology
- Language
- English
- Resource Type
- Journal article
- PMID
- 10657422
- Record Identifier
- 991031559291102976
Journal article
The Stroke Prognosis Instrument II (SPI-II): A Clinical Prediction Instrument for Patients With Transient Ischemia and Nondisabling Ischemic Stroke
Stroke (1970), Vol.31(2), pp.456-462
2000-02
PMID: 10657422
Metrics
18 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.105 Strokes
- 1.105.142 Stroke
- Web Of Science research areas
- Clinical Neurology
- Peripheral Vascular Disease
- ESI research areas
- Neuroscience & Behavior
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites